Rachel Lynn Karabenick

Statistics

Publications

Citations

168

H-Index

Active since

2003

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

University of Michigan

National Institutes of Health

Rachel Lynn Karabenick is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in neuroscience, behavioral pharmacology, and pharmacology.

Publications per year

2003–2004

Publications

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

William E. Fantegrossi, Tomek Godlewski, Rachel Lynn Karabenick et al. · Psychopharmacology · 2003 · 119 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice

William E. Fantegrossi, Christina Lynn Kiessel, Prescott T. Leach et al. · Psychopharmacology · 2004 · 49 citations · Full text

Medicine, Neuroscience, Pharmacology +6

1–2 of 2